Previous close | 13.13 |
Open | 13.21 |
Bid | 13.15 x 3200 |
Ask | 13.17 x 1300 |
Day's range | 13.10 - 13.50 |
52-week range | 13.03 - 30.41 |
Volume | |
Avg. volume | 4,837,579 |
Market cap | 2.225B |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.34 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 19.70 |
PURCHASE, NY, April 15, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its first quarter 2024 results, previously scheduled for 4:30 p.m. E.T. on April 25, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants,
PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For
The leader of struggling telemedicine provider Teladoc Health has left effective immediately, the company announced Friday. Teladoc gave no reason for the departure of CEO Jason Gorevic. Teladoc said Chief Financial Officer Mala Murthy would serve as acting CEO while the company looks for a permanent replacement.